Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Jennifer Stichman, MD, and Dennis J. Boyle, MD  |  Issue: April 2015  |  April 1, 2015

In some cases, medications are perceived as being ineffective. Many RA medications take months to reach full efficacy. Patients in remission sometimes stop their medications. It’s incumbent on us to outline the time line for a sufficient trial of medication and to teach that remission is not synonymous with cure.

Initiation of urate-lowering therapy is another time that anticipatory counseling can make a difference: It may be hard to convince a patient who flares after starting allopurinol that this is a medicine that really treats gout! Preemptive discussion of the potential to have flares may prevent self-discontinuation of the medication.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Importantly, patients are less likely to take medications if they hold beliefs or have concerns that conflict with the provider’s beliefs and concerns. Factors that drive rheumatologists to change medication regimens in rheumatoid arthritis are what we expect—swollen joint counts, physician global assessment, worsening erosions and increased disease activity compared with the prior visit. In contrast, when patients were asked what may lead them to escalate care, they cite painful joint counts, current physical functioning, satisfaction with current DMARDs and trust in their rheumatologist.8 Exploration of patient values and preferences around illness and medication can help tease out if patients are likely to be taking a prescribed regimen.

What Can We Do about It?

Improving adherence in chronic disease is challenging. Interventions that have been studied and found helpful almost all require a substantial amount of effort and resources. These interventions have to be continued indefinitely, because there is no evidence that low adherence can be “cured.”9

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One step that can be taken is to simplify dosage regimens when possible. Are there any medications that can be discontinued? Is a long-acting version available to decrease the dosing frequency?

Also, we should spend time on the front end to elicit patient concerns and make sure we are connected to the patient so they can share their fears and concerns.

Employing the teach-back method at the end of a visit is an excellent way to ensure patient understanding. One might say to the patient at the end of a visit, “What are you going to tell your spouse about our conversation and what medications you will be taking?” This technique can reveal important gaps in patient understanding.

Writing down the diagnosis highlights and medicine regimens may also improve education and retention.

Communication is at the heart of the adherence issue. The best predictor of adherence is the clinician–patient relationship. You need to understand the patient’s own belief about their illness. You need to show empathy by using good body language and by voicing concern about how the disease is affecting the patient.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:adherenceBoyleMedicationpatient carerheumatology

Related Articles

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Gout Treatments Effective If Patients Maintain Lifelong Adherence to Therapies

    January 19, 2017

    Although gout is one of the most effectively treated of all rheumatic diseases, it is among the worst-managed diseases long term, as shown by many studies. “Treatments are excellent, yet are dramatically under-utilized,” says Theodore Fields, MD, FACP, rheumatologist, Hospital for Special Surgery (HSS), New York. “This is because some gout patients feel better between…

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences